Back
Unity Software Vs. Akero Therapeutics Industry Stock Comparison
Buy
55
U
Unity Software
Last Price:
$22.82
Seasonality Move:
21.86%
Sell
26
AKRO
Akero Therapeutics
Last Price:
$38.83
Seasonality Move:
19.25%
Buy
55
Unity Software (U)
is a Buy
Is Unity Software a Buy, Sell or Hold?
-
The current Unity Software [U] share price is $22.81. The Score for U is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
U is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $38.87. The Score for AKRO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
U Stock Price Chart
What is Unity Software's stock price today?
-
The Unity Software share price today is $22.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and U is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $38.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
U Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 60.76 | Buy |
Chaikin Money Flow: | 9672758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.6 - 22.12) | Buy |
Bollinger Bands (100): | (19.74 - 23.96) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 44.12 | Sell |
Chaikin Money Flow: | -1107772 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.88 - 43.36) | Sell |
Bollinger Bands (100): | (31.04 - 49.42) | Sell |
U Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.4 | Buy |
20-day SMA: | 21.36 | Buy |
50-day SMA: | 20.73 | Buy |
200-day SMA: | 21.05 | Buy |
8-day EMA: | 21.67 | Buy |
20-day EMA: | 21.24 | Buy |
50-day EMA: | 21.19 | Buy |
200-day EMA: | 21.97 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.41 | Sell |
20-day SMA: | 41.45 | Sell |
50-day SMA: | 41.25 | Sell |
200-day SMA: | 34.44 | Buy |
8-day EMA: | 40.22 | Sell |
20-day EMA: | 40.84 | Sell |
50-day EMA: | 41.07 | Sell |
200-day EMA: | 36.09 | Buy |
Unity Software Earnings Growth & U Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.12 per share, and an increase next year of $0.05 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.70 per share.
Unity Software Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |